Position in JANX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$155,536,732
+$1,118,969 QoQ
Shares Held
11,189,693
0.0% QoQ
Ownership
18.3%
of shares outstanding
% of Portfolio
1.65%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RA CAPITAL MANAGEMENT, L.P. holds $9,134,713,488 across 74 Biotechnology names. JANX ranks #15 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
10,281,496 | $2,351,686,580 | |
| 2 | PCVX |
Vaxcyte, Inc.
|
11,474,599 | $666,788,947 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
6,666,837 | $579,814,813 | |
| 4 | TYRA |
Tyra Biosciences, Inc.
|
12,198,625 | $467,207,337 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
9,905,045 | $397,093,254 | |
| 6 | EWTX |
Edgewise Therapeutics, Inc.
|
10,428,437 | $328,495,765 | |
| 7 | NAMS |
NewAmsterdam Pharma Co N.V.
|
9,550,191 | $305,701,613 | |
| 8 | NUVL |
Nuvalent, Inc.
|
2,534,145 | $259,623,155 |
All Filings in JANX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $155,536,732 | 11,189,693 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $154,417,763 | 11,189,693 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $273,476,096 | 11,189,693 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $258,481,908 | 11,189,693 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $302,121,711 | 11,189,693 | Shares | Sole | 2025-05-15 | |
| 2025-03-06 | $368,119,842 | 11,971,377 | Shares | Sole | 2025-03-10 | |
| 2024-12-31 | $554,977,008 | 10,365,652 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $416,395,570 | 9,165,652 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $383,949,162 | 9,165,652 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $98,347,445 | 9,165,652 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $102,920,544 | 8,670,644 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $104,914,792 | 8,670,644 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $114,192,381 | 8,670,644 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $117,400,519 | 8,670,644 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $105,868,563 | 8,670,644 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $124,337,034 | 8,670,644 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $171,071,806 | 8,670,644 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $187,546,029 | 8,670,644 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $216,332,567 | 8,670,644 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||